Fam Cancer. 2012 Dec;11(4):675-80. doi: 10.1007/s10689-012-9558-y.
Nearly one-third of the identified MSH6 germline mutations deal with single amino acid substitutions. For an effective genetic counselling it is necessary to clearly elucidate by functional tools the specific sub-processes underlying the mismatch repair (MMR) misfunctioning in MSH6 non-truncating mutants. Since the MMR repair pathway occurs in the nucleus, we suppose the impairment of MutSα nuclear trafficking to be a possible Lynch syndrome susceptibility causative mechanism. In the present study the MMR status of the tumour, the main clinical features of mutation carriers and population data associated to the MSH6 missense variants, were complemented with computational data about tolerability predictions and amino acid substitution conservation. The selected panel of ten potentially pathogenic MSH6 mutations was analyzed in a homologous expression system for possible deleterious effects on nucleo-cytoplasmic shuttling through the assessment of the sub-cellular localization of the corresponding mutated proteins. Localization analysis results do not reveal an apparent role of MSH6 missense mutations in nuclear import impairment and provide the first hint to exclude the MSH6 nuclear translocation sub-process as a possible causative mechanisms of MMR misfunctioning.
近三分之一的鉴定 MSH6 种系突变涉及单个氨基酸替换。为了进行有效的遗传咨询,有必要通过功能工具清楚地阐明 MSH6 非截断突变体中错配修复 (MMR) 功能障碍的特定亚过程。由于 MMR 修复途径发生在核内,我们假设 MutSα 核易位受损可能是林奇综合征易感性的潜在致病机制。在本研究中,肿瘤的 MMR 状态、突变携带者的主要临床特征以及与 MSH6 错义变异相关的人群数据,与关于耐受性预测和氨基酸替换保守性的计算数据相结合。通过评估相应突变蛋白的核质穿梭情况,在同源表达系统中分析了选定的十个可能具有致病性的 MSH6 突变,以研究其对核质穿梭的潜在有害影响。定位分析结果并未显示 MSH6 错义突变在核输入受损中的明显作用,并首次提示排除 MSH6 核易位亚过程作为 MMR 功能障碍的可能致病机制。